Cita APA

Kameda, H., Uechi, E., Atsumi, T., Abud‐Mendoza, C., Kamei, K., Matsumoto, T., . . . Radominski, S. C. (2020). A comparative study of PF‐06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis. Int J Rheum Dis.

Citación estilo Chicago

Kameda, Hideto, et al. "A Comparative Study of PF‐06438179/GP1111 (an Infliximab Biosimilar) and Reference Infliximab in Patients With Moderate to Severe Active Rheumatoid Arthritis: A Subgroup Analysis." Int J Rheum Dis 2020.

Cita MLA

Kameda, Hideto, et al. "A Comparative Study of PF‐06438179/GP1111 (an Infliximab Biosimilar) and Reference Infliximab in Patients With Moderate to Severe Active Rheumatoid Arthritis: A Subgroup Analysis." Int J Rheum Dis 2020.